• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

稀释的困惑:肉毒杆菌毒素的简易给药方法

The Dilution Confusion: Easy Dosing for Botulinum Toxins.

作者信息

Bass Kaplan Julie

机构信息

Julie Bass Kaplan, MSN, RN, CPSN, CANS, HCMT, PHN, is Founder Disappearing Act Laser & Skin Rejuvenation, Founder JBK Aesthetics, Redding California.

出版信息

Plast Surg Nurs. 2016 Jan-Mar;36(1):24-7. doi: 10.1097/PSN.0000000000000121.

DOI:10.1097/PSN.0000000000000121
PMID:26933983
Abstract

Aesthetic practitioners prefer various reconstitution volumes for botulinum toxins (BoNTAs). Some injectors prefer larger volumes of bacteriostatic normal saline (NaCl) to achieve a larger diffusion in certain areas and a smaller volume for more precise administration of the BoNTA. Some practitioners believe dilution volumes do not matter at all in relation to spread or diffusion, asserting the diffusion area is simply dose-related. It can get confusing when there is more than one injector in an office, different volumes of saline, and more than one type of syringe to administer the neurotoxin. This leaves possibilities for confusion and dosage errors. This article explores four steps to take the confusion out of reconstituting BoNTAs and delivering accurate and consistent doses within a medical office.

摘要

美容从业者对肉毒杆菌毒素(BoNTAs)的复溶体积有不同偏好。一些注射者更喜欢使用较大体积的抑菌生理盐水(NaCl),以便在某些区域实现更大范围的扩散,而在更精确地注射肉毒杆菌毒素时则使用较小体积。一些从业者认为稀释体积与扩散或弥散毫无关系,声称扩散面积仅仅与剂量相关。当办公室中有多名注射者、不同体积的生理盐水以及不止一种类型的注射器来注射神经毒素时,情况就会变得混乱。这就增加了混淆和剂量错误的可能性。本文探讨了四个步骤,以消除在复溶肉毒杆菌毒素以及在医疗机构内提供准确一致剂量方面的混乱。

相似文献

1
The Dilution Confusion: Easy Dosing for Botulinum Toxins.稀释的困惑:肉毒杆菌毒素的简易给药方法
Plast Surg Nurs. 2016 Jan-Mar;36(1):24-7. doi: 10.1097/PSN.0000000000000121.
2
Botulinum neurotoxin type A-ABO (Dysport): clinical indications and practice guide.A型肉毒毒素-A(丽舒妥):临床适应证和实践指南。
Aesthet Surg J. 2009 Nov;29(6 Suppl):S72-9. doi: 10.1016/j.asj.2009.09.016.
3
Pharmaceutical, biological, and clinical properties of botulinum neurotoxin type A products.A型肉毒杆菌神经毒素产品的药学、生物学及临床特性
Drugs R D. 2015 Mar;15(1):1-9. doi: 10.1007/s40268-014-0077-1.
4
Response to Commentary by W. Jost on: Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products.对W. 约斯特就《A型肉毒杆菌神经毒素产品的药学、生物学及临床特性》所发表评论的回应
Drugs R D. 2015 Jun;15(2):217-8. doi: 10.1007/s40268-015-0091-y.
5
Gummy smile and botulinum toxin: a new approach based on the gingival exposure area. Gummy 微笑和肉毒毒素:一种基于牙龈暴露面积的新方法。
J Am Acad Dermatol. 2010 Dec;63(6):1042-51. doi: 10.1016/j.jaad.2010.02.053.
6
Assessment of Botulinum Toxin Aesthetic Outcomes: Clinical Study vs Real-World Practice.A型肉毒毒素美学效果评估:临床研究与实际应用对比
JAMA Dermatol. 2015 Nov;151(11):1177-8. doi: 10.1001/jamadermatol.2015.2881.
7
Consideration of muscle mass in glabellar line treatment with botulinum toxin type A.A型肉毒毒素治疗眉间纹时对肌肉质量的考量。
J Drugs Dermatol. 2012 Sep;11(9):1041-5.
8
Pharmacological differences and clinical implications of various botulinum toxin preparations: a critical appraisal.各种肉毒杆菌毒素制剂的药理学差异及临床意义:批判性评价
Funct Neurol. 2018 Jan/Mar;33(1):7-18. doi: 10.11138/fneur/2018.33.1.007.
9
Clinical resistance to three types of botulinum toxin type A in aesthetic medicine.美容医学中对三种A型肉毒杆菌毒素的临床耐药性。
J Cosmet Dermatol. 2014 Dec;13(4):346-8. doi: 10.1111/jocd.12108.
10
The use of botulinum toxin type A in cosmetic facial procedures.A型肉毒毒素在美容面部治疗中的应用。
Int J Oral Maxillofac Surg. 2011 Feb;40(2):127-33. doi: 10.1016/j.ijom.2010.09.014. Epub 2010 Oct 20.

引用本文的文献

1
Comparing Ready-to-Use and Powder AbobotulinumtoxinA for Glabellar Lines: A Randomized, Controlled, Triple-Blinded Clinical Trial.比较即用型与粉末型阿柏毒素A治疗眉间纹:一项随机、对照、三盲临床试验。
J Cosmet Dermatol. 2025 Jul;24(7):e70308. doi: 10.1111/jocd.70308.
2
Review: Botulinum Toxin for Treatment of Focal Limb Dystonia.综述:肉毒杆菌毒素治疗局灶性肢体肌张力障碍
Toxins (Basel). 2025 Mar 4;17(3):122. doi: 10.3390/toxins17030122.
3
Intradermal Microdroplet Injection of Standard-Diluted Incobotulinumtoxin A for the Treatment of Erythematotelangiectatic Rosacea: A Study From a Dermatology Center in Medellín, Colombia.
皮内微滴注射标准稀释的英科博妥素A治疗红斑毛细血管扩张型玫瑰痤疮:来自哥伦比亚麦德林一家皮肤科中心的研究
Cureus. 2025 Feb 13;17(2):e78957. doi: 10.7759/cureus.78957. eCollection 2025 Feb.
4
NivobotulinumtoxinA in the Treatment of Glabellar Lines With or Without Concurrent Treatment of Lateral Canthal Lines in Two Phase 3 Clinical Trials.在两项3期临床试验中,肉毒杆菌毒素A用于治疗眉间纹,无论是否同时治疗外眦纹。
Aesthet Surg J. 2025 Mar 17;45(4):404-413. doi: 10.1093/asj/sjae233.
5
Extraction and injection of botulinum toxin with less wastage.肉毒杆菌毒素的提取与注射,减少浪费。
Skin Res Technol. 2024 Jul;30(7):e13816. doi: 10.1111/srt.13816.
6
The mechanisms of action and use of botulinum neurotoxin type A in aesthetics: Key Clinical Postulates II.A型肉毒杆菌神经毒素在美容领域的作用机制与应用:关键临床假设II。
J Cosmet Dermatol. 2020 Nov;19(11):2785-2804. doi: 10.1111/jocd.13702. Epub 2020 Sep 16.
7
Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines.阿巴司琼毒素 A 的液体制剂:6 个月、3 期、双盲、随机、安慰剂对照研究,单次使用、即用型毒素治疗中重度眉间纹。
Aesthet Surg J. 2020 Jan 1;40(1):93-104. doi: 10.1093/asj/sjz003.
8
Efficacy and Safety of Botulinum Toxin Type A in Spasticity Caused by Spinal Cord Injury: A Randomized, Controlled Trial.A型肉毒毒素治疗脊髓损伤后痉挛的疗效和安全性:一项随机对照试验。
Med Sci Monit. 2018 Nov 13;24:8160-8171. doi: 10.12659/MSM.911296.
9
Dynamic Relaxers of the Face.面部动态松弛剂
J Cutan Aesthet Surg. 2018 Apr-Jun;11(2):47-50. doi: 10.4103/JCAS.JCAS_61_18.